Results 131 to 140 of about 298,741 (199)

Human papillomavirus \u2013 2019

This online series of 15 webinars provides an overview of the principles of vaccination, general recommendations, immunization strategies for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent them.

core  

Women's experiences, responses, and coping strategies when testing positive for human papillomavirus in cervical cancer screening: A qualitative study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2104-2113, October 2026.
This study demonstrates that women's experiences following an hrHPV diagnosis within cervical screening extend beyond individual reactions to medical information, encompassing complex psychological, social, and cultural dimensions that influence how women interpret and manage the diagnosis.
Joan Hansen, Beth J. Maclin, Birgitte Folmann, Jane Ege Møller, Ane Kersti Skaarup Knudsen, Vibeke Raaby, Anne Hammer   +6 more
wiley   +1 more source

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants. [PDF]

Hum Vaccin Immunother, 2022
Garland SM, Anagani M, Bhatla N, Chatterjee S, Lalwani S, Ross C, Group T, Lin J, Luxembourg A, Walia A, Tu Y.   +10 more
europepmc   +1 more source

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 10, Page 1412-1416, October 2026.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann, Ulrike Wieland, Steffi Silling, Frank Oellig, David Chromy, Julia Hyun, Thilo Gambichler, Alexander Kreuter   +7 more
wiley   +1 more source

Ethical Challenges to Improving Access to Human Papillomavirus Vaccines in Low- and Middle-Income Countries. [PDF]

NEJM Evid, 2022
Eke AC, Kerry VB.
europepmc   +1 more source

Achieving Cancer Prevention Equity: A Policy Analysis of American Cancer Society HPV Vaccination Guidelines

Journal of Advanced Nursing, Volume 82, Issue 10, Page 9384-9398, October 2026.
ABSTRACT Aim To examine the American Cancer Society's HPV vaccination guidelines through a nursing policy analysis framework, assessing justice and equity outcomes in cancer prevention policy implementation. Background Human papillomavirus vaccination remains critical for cancer prevention, yet persistent health disparities undermine equity goals ...
Grace K. Kyei, Evans K. Kyei, Rockson Ansong   +2 more
wiley   +1 more source

Intralesional bivalent and quadrivalent human papillomavirus vaccines didn't significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial. [PDF]

Arch Dermatol Res, 2023
Fawzy M, Nofal E, Abdelkhalek N, Ehab R.
europepmc   +1 more source

School‐Based Access to and Delivery of Oral Health Care

Journal of School Health, Volume 96, Issue 10, October 2026.
ABSTRACT Background Given the importance of oral health to overall health, inclusive evidence‐based interventions to improve health care access, quality of life, and learning and development through school‐based delivery of oral health care are needed for all children, including those with special needs. Contributions to Practice Integrated delivery of
Mary E. Northridge, Lynn Gargano, Margaret K. Mason   +2 more
wiley   +1 more source

On Imported and Domestic Human Papillomavirus Vaccines: Cognition, Attitude, and Willingness to Pay in Chinese Medical Students. [PDF]

Front Public Health, 2022
Zhou L, Gu B, Xu X, Li Y, Cheng P, Huo Y, Liu G, Zhang X.   +7 more
europepmc   +1 more source

Current Status of Human Papillomavirus Vaccines

Journal of the Formosan Medical Association, 2010
Barbara Ma, Richard Roden, T.-C. Wu
doaj   +1 more source